SEC Form 5 · accession 0001387131-17-000843
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert G Finizio
Officer — CEO · Director · 10% Owner
Period of report
Dec 31, 2016
Accepted (ET)
Feb 14, 2017 · 5:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 29, 2016 | G | 165,000 | $0.00 | D | 18,651,059 | D | |
| Common Stock | Dec 30, 2016 | G | 7,500 | $0.00 | D | 18,643,559 | D | |
| Common StockF2 | holding | — | — | — | 1,827,440 | I | See footnote | |
| Common StockF3 | holding | — | — | — | 172,560 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 20,000 shares of Common Stock that were inadvertently reported as being disposed of by gift on the Reporting Person's Form 5 filed with the SEC on February 16, 2016.
- F2By the Reporting Person's Grantor-Retained Annuity Trust (the "Finizio GRAT").
- F3By Robert Finizio Revocable Trust; these shares were previously reported as held by the Finizio GRAT.